A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Clinical trial NCT03797391 · UNKNOWN

Trial details

NCT number: NCT03797391
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis Non-Small-Cell Lung Cancer

Start date: 2018-12-13
Primary completion: 2025-03-14
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.